Skip to main content
Premium Trial:

Request an Annual Quote

Sigma-Aldrich Q4 Revenues Jump 16.7 Percent Atop Increased R&D Spending, Profit

NEW YORK, Feb. 15 (GenomeWeb News) - Sigma-Aldrich yesterday reported a 16.7-percent increase in revenues and a 4.8-percent rise in net income for the fourth quarter.

 

Sales for the three months ended Dec. 31, 2005, rose to $410.5 million from $351.9 million in the year-ago period. The company's scientific research and biotechnology business units increased by 2.7 percent and 12.5 percent, respectively, year over year.

 

R&D expenses for the fourth quarter grew 10 percent to $12.2 million from $11.1 million in Q4 2004, Sigma-Aldrich said.

 

Sigma-Aldrich's net income for the fourth quarter grew to $57.3  million from $54.7 million in Q4 2004.

 

As of Dec. 31, Sigma-Aldrich had approximately $98.6 million in cash and cash equivalents.

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.